Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Walnut protein is a naturally derived protein extracted from walnuts, recognized for its nutritional value and diverse functional properties. It is being investigated for its potential in oral immunotherapy (OIT) to induce desensitization and tolerance in individuals with tree nut allergies by modulating immune responses. Beyond its therapeutic potential, walnut protein is extensively studied as a functional food ingredient due to its emulsifying, foaming, and gelling capabilities, which can be enhanced through various physical and chemical modifications. It is also a source of bioactive peptides with potential health benefits, including antihypertensive effects through angiotensin-converting enzyme (ACE) inhibition, and antidiabetic properties via dipeptidyl peptidase-IV (DPP-IV) inhibition. Furthermore, modified walnut protein hydrolysates can form complexes that enhance the bioavailability of essential minerals like iron, positioning it as a promising component for nutritional supplements and functional foods.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on walnut protein.